Skip to content
b_luis

Luis Nunez, Ph.D., MBA

CTO

b_luis

Luis Nunez, Ph.D., MBA

CTO

Dr. Luis Núñez, Founder and Chief Technology Officer for BioTarget, LNK Chemsolutions LLC, and Iasotek LLC, nanotechnology based companies formed to develop medical products and diagnostics tools.  Over the past ten years,   Dr. Núñez has focused on biomedical materials and published highly cited academic literature and developed technology though his companies on the use of fluid micro-jets to make ultrafine particles, capsules, fibers and tubules for a variety of applications (e.g., treatment of cancers, inflammatory diseases, mental disorders, and tissue regeneration) . Furthermore, Dr.Núñez developed a combination of plasmon resonance nanomaterial and non-linear optics to increase sensitivity in diagnostic kits.   Dr. Núñez was a chemist at Argonne National Laboratory. His Argonne career included leading research and development efforts in the areas of nanotechnology, material sciences, physics, higher energy physics, mathematics and computing sciences, biosciences, the Rare Isotope Accelerator Initiative and educational programs. Dr. Núñez also assisted the U.S. Department of Energy (DOE) with the development of a new nuclear reactor research and development program while on assignment as a Staff Scientist. Dr. Núñez received a PhD in Physical Chemistry from Northern Illinois University and an MBA from Northwestern University. Dr. Núñez is also Board member for St. Xavier University, and Illinois Mathematics and Science Academy (IMSA).

Scroll To Top